Jean-Luc Plantier
7Patents
4h-index
7Co-inventors
46Inventor score
Filing activity: Nov 15, 1999 → Feb 3, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6271025A | Modified factor VIII cDNA | Human Necessities | 17 | Expired |
| US6780614B2 | Modified factor VIII cDNA and its use for the production of factor VIII | Chemistry; Metallurgy | 9 | Expired |
| US6800461B2 | Modified factor VIII cDNA | Human Necessities | 9 | Expired |
| US6419921B1 | DNA-constructs of blood clotting factors and P-Selectin | Chemistry; Metallurgy | 5 | Expired |
| US9700603B2 | Use of antidotes to coagulation inhibitors indicated in the prevention or treatment of thromboembolic pathologies | Physics | 1 | Active |
| US8623824B2 | VIII factors for the treatment of type A hemophilia | Human Necessities | 0 | Active |
| US10364424B2 | Factor X mutants | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.